144 related articles for article (PubMed ID: 33571728)
1. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.
Tsuchiya K; Ohuchi M; Yamane N; Aikawa H; Gatanaga H; Oka S; Hamada A
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28762239
[TBL] [Abstract][Full Text] [Related]
3. HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma.
Zheng Y; Aboura R; Boujaafar S; Lui G; Hirt D; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Gana I
J Pharm Biomed Anal; 2020 Apr; 182():113119. PubMed ID: 32004775
[TBL] [Abstract][Full Text] [Related]
4. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
[TBL] [Abstract][Full Text] [Related]
5. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
Yamada E; Takagi R; Sudo K; Kato S
J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
[TBL] [Abstract][Full Text] [Related]
6. A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma.
Bennetto-Hood C; Tabolt G; Savina P; Acosta EP
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():225-32. PubMed ID: 24361860
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma.
Bollen PDJ; de Graaff-Teulen MJA; Schalkwijk S; van Erp NP; Burger DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():76-84. PubMed ID: 30572204
[TBL] [Abstract][Full Text] [Related]
8. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
9. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma.
Du P; Han X; Li N; Wang H; Yang S; Song Y; Shi Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():28-35. PubMed ID: 25063925
[TBL] [Abstract][Full Text] [Related]
11. Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots.
Akinloye A; Eniayewu O; Adeagbo B; Bolaji O; Olagunju A
Ther Drug Monit; 2022 Jun; 44(3):430-437. PubMed ID: 34629444
[TBL] [Abstract][Full Text] [Related]
12. A rapid validated UV-HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir in their dosage form.
Estan-Cerezo G; García-Monsalve A; Soriano-Irigaray L; Rodríguez-Lucena FJ; Navarro-Ruiz A
Rev Esp Quimioter; 2017 Jun; 30(3):195-200. PubMed ID: 28361525
[TBL] [Abstract][Full Text] [Related]
13. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
Fayet A; Béguin A; Zanolari B; Cruchon S; Guignard N; Telenti A; Cavassini M; Günthard HF; Buclin T; Biollaz J; Rochat B; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1057-69. PubMed ID: 19332396
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of ultra performance liquid chromatography-tandem mass spectrometry method for the simultaneous estimation of dolutegravir, lamivudine and tenofovir in bulk and tablet dosage form.
Veerareddy V; Dodda S; Gangarapu K
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):249-255. PubMed ID: 34851199
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A
J Pharm Biomed Anal; 2017 May; 138():223-230. PubMed ID: 28219799
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
West RE; Oberly PJ; Saylor AJ; Riddler SA; Nolin TD; Devanathan AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124164. PubMed ID: 38823149
[TBL] [Abstract][Full Text] [Related]
17. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization.
Zhang J; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):47-56. PubMed ID: 16815762
[TBL] [Abstract][Full Text] [Related]
18. A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection.
Wang X; Penchala SD; Amara A; Else L; McClure M; Boffito M
Ther Drug Monit; 2016 Jun; 38(3):327-31. PubMed ID: 26859200
[TBL] [Abstract][Full Text] [Related]
19. Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.
Li W; Lin H; Smith HT; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1927-33. PubMed ID: 21680264
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV.
Rigo-Bonnin R; García-Tejada L; Mas-Bosch V; Imaz A; Manuel Tiraboschi J; Scévola S; Niubó J; Navarro-Alcaraz A; Podzamczer D
Clin Chim Acta; 2024 Jan; 552():117678. PubMed ID: 38042460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
